Restatement of Previously Issued Financial Statements (Details) - Schedule of the restatement on each financial statement - USD ($)	4 Months Ended	7 Months Ended
	Sep. 30, 2020	Dec. 31, 2020	Aug. 20, 2020
As Previously Reported [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability
Common Stock Subject to Possible Redemption	300,465,469	303,078,515	285,817,300
Common Stock	949	963	1,004
Additional Paid-in Capital	5,124,471	6,511,411	5,000,015
Accumulated Deficit	(125,414)	(1,512,369)	(1,013)
Shareholder’s Equity		5,000,001
Weighted average shares outstanding of non-redeemable common stock
Change in fair value of warrant liability
Transaction costs allocable to warrant liability within formation and operational costs
Net loss	$ (125,414)	$ (1,512,369)
Weighted average common shares subject to possible redemption outstanding, basic and diluted (in Shares)	30,138,480	30,351,355
Weighted average non-redeemable common shares outstanding, basic and diluted (in Shares)	8,111,107	8,691,291
Basic and diluted net loss per share, nonredeemable common stock (in Dollars per share)	$ (0.02)	$ (0.18)
Cash Flow Statement for the Period from May 27, 2020 (inception) to December 31, 2020
Share-based compensation for warrant liabilities
Transaction costs allocable to warrant liabilities
Initial classification of warrant liabilities
Adjustments [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	$ 33,198,921	147,602,681	30,645,000
Common Stock Subject to Possible Redemption	(33,198,921)	(147,602,683)	(30,645,000)
Common Stock	332	1,476	306
Additional Paid-in Capital	5,029,540	119,432,158	4,306,214
Accumulated Deficit	(5,029,872)	(119,433,632)	(4,306,520)
Shareholder’s Equity		6
Weighted average shares outstanding of non-redeemable common stock
Change in fair value of warrant liability	723,352	115,127,112
Transaction costs allocable to warrant liability within formation and operational costs	4,306,520	4,306,520
Net loss	$ (5,029,872)	$ (119,433,632)
Weighted average common shares subject to possible redemption outstanding, basic and diluted (in Shares)	(3,216,303)	(3,287,735)
Weighted average non-redeemable common shares outstanding, basic and diluted (in Shares)	(2,799,035)	2,005,636
Cash Flow Statement for the Period from May 27, 2020 (inception) to December 31, 2020
Share-based compensation for warrant liabilities		$ 3,092,846
Transaction costs allocable to warrant liabilities		1,213,674
Initial classification of warrant liabilities		32,475,569
As Restated [Member]
Condensed Financial Statements, Captions [Line Items]
Warrant Liability	$ 33,198,921	147,602,681	30,645,000
Common Stock Subject to Possible Redemption	271,266,548	15,547,583	255,172,300
Common Stock	1,281	2,439	1,310
Additional Paid-in Capital	10,154,011	125,943,569	9,306,210
Accumulated Deficit	(5,155,286)	(120,946,001)	$ (4,307,533)
Shareholder’s Equity		5,000,007
Weighted average shares outstanding of non-redeemable common stock
Change in fair value of warrant liability	723,532	115,127,112
Transaction costs allocable to warrant liability within formation and operational costs	4,306,520	4,306,520
Net loss	$ (5,155,286)	$ (120,946,001)
Weighted average common shares subject to possible redemption outstanding, basic and diluted (in Shares)	26,922,176	27,063,620
Weighted average non-redeemable common shares outstanding, basic and diluted (in Shares)	5,312,072	10,696,927
Basic and diluted net loss per share, nonredeemable common stock (in Dollars per share)	$ (0.97)	$ (11.31)
Cash Flow Statement for the Period from May 27, 2020 (inception) to December 31, 2020
Share-based compensation for warrant liabilities		$ 3,092,846
Transaction costs allocable to warrant liabilities		1,213,674
Initial classification of warrant liabilities		$ 32,475,569